Moderna hails successful trial of combined Covid and flu shot
Vaccine maker to seek approval for jab as it tries to diversify product pipeline
Vaccine maker to seek approval for jab as it tries to diversify product pipeline
Focus on new treatments as Covid vaccine sales fell from $18.4 billion in 2022 to $6.8 billion last year
Biotech blames weaker US sales after lowering full-year forecast
Hospitalisations from Covid-19 have crept up in recent weeks, although the rise is lower than the same time last year
Researchers believe personalised medicine and vaccines are probably the next big thing in the quest to reduce cancer deaths
Chief executive of Simon Property Group saw pay more than triple last year to $35.4m even as shareholder return dropped by 22%
European health officials have advocated portfolio diversity to help fight different variants
More than 850,000 doses of past-expiry date Covid-19 vaccines thrown out
Dublin market outperforms international peers as it finishes the day up 1.7% on the back of strong rallies
Workhuman, which specialises in employee reward and incentive programmes for companies worldwide, employs 600 people in Ireland
Novavax had a terrible week while Pfizer and Moderna are well off their pandemic highs
Manufacturing woes meant it lost out in race to market with its Covid vaccine
Inside Business podcast with Ciarán Hancock
Study suggests combination with Merck immunotherapy drug reduces risk of death in high-risk patients
Sales drop 43% in third quarter as primary immunisation drives reach completion
Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic
Top jab makers lose combined $10bn of market value amid fears over growing public apathy
Vaccines also include original version of virus
US biotech claims rival Covid vaccine makers infringed patents underpinning jabs
New book details how talent, leaps of faith and dogged determination brought the pharma company to world attention in 2020
President hails ‘monumental step forward’ in battle against virus but parents have been more cautious in inoculating children
Interim results from its clinical trial showed the jab is safe and highly effective, company said
Interview: Horizon Therapeutics chief Tim Walbert sees Dublin at heart of its international expansion
With the virus rampant despite jabs, trials are underway to create intranasal vaccines
Pyongyang says it has kept its population Covid-free by sealing the country’s borders
Adoption of committee reports confirms extension intended to facilitate travel
Cantillon: Emerging markets surprise observers with vaccine preferences
Proxy advisers back shareholder resolutions as new shot shows promising results
Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge
Ukraine’s president Zelenskiy makes cameo at scandal free ceremony after Oscars chaos
Request is significantly broader than Pfizer and its German partner BioNTech’s
‘We don’t need to push it in places we are not needed or wanted,’ says drugmaker’s VP
Three doses can protect against serious illness and death for a long time, studies suggest
European Medicines Agency says no evidence to suggest vaccines affect fertility
US mRNA pioneer in late stage discussions with government over move that would boost post-Brexit life sciences strategy
‘I was called an anti-vaxxer, and I took exception to that. My children are vaccinated’
Pharmaceutical manufacturer to focus on cancer and immunology
Increased infection and rush for boosters over season has reduced eligible population
Most are mild to moderate and many had resolved or were resolving when reported
Dr Barney Graham’s discovery was a key step in development of Covid-19 vaccines
Decreased demand after Christmas and high infection rate caused excess of supplies
Drug-maker to submit data to regulators worldwide given urgent need for boosters
Analysis: There are far bigger issues for Nphet to resolve around inoculation policy
Freemasons say they have been previously targeted by ‘ridiculous’ campaign
Early research suggests Omicron may cause milder illnesses than previous variants
Shareholder proposal demands pharma group open up Covid-19 vaccine tech to poorer countries
Who had a good year? Rachael Blackmore for one. Who didn’t? Stephen Donnelly, arguably
Net Results: From mRNA vaccines to discontent with Data Protection Commissioners
The data suggests those infected in UK are 40 per cent less likely to be hospitalised for a night or more
Just 13 per cent of people in Africa have received at least one dose of a Covid vaccine
The company made between 700m and 800m Covid-19 vaccine doses this year
Validity will be extended after booster shot without a time limit
Travel stocks fell 1 per cent, but were above their intra-day lows touched earlier in session
Staff work around the clock to get vaccines to every corner of the State
Crosswords & puzzles to keep you challenged and entertained
Inquests into the nightclub fire that led to the deaths of 48 people
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices